EYES - Second Sight Medical Products, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue6,8967,9643,9858,950
Cost of Revenue4,8885,11710,0765,293
Gross Profit2,0082,847-6,0913,657
Operating Expenses
Research Development14,60510,9558,0506,546
Selling General and Administrative22,02820,50119,06917,158
Non Recurring----
Total Operating Expenses41,52136,57337,19528,997
Operating Income or Loss-34,625-28,609-33,210-20,047
Income from Continuing Operations
Total Other Income/Expenses Net-469933129
Earnings Before Interest and Taxes-34,625-28,609-33,210-20,047
Interest Expense----
Income Before Tax-35,094-28,516-33,179-20,018
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-35,094-28,516-33,179-20,018
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-35,094-28,516-33,179-20,018
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-35,094-28,516-33,179-20,018